SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-032233
Filing Date
2023-07-07
Accepted
2023-07-07 16:07:07
Documents
14
Period of Report
2023-07-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K revb-20230706.htm   iXBRL 8-K 64234
2 EX-3.2 revb-ex3_2.htm EX-3.2 240231
  Complete submission text file 0000950170-23-032233.txt   504578

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT revb-20230706.xsd EX-101.SCH 3514
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT revb-20230706_lab.xml EX-101.LAB 19607
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT revb-20230706_def.xml EX-101.DEF 14807
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT revb-20230706_pre.xml EX-101.PRE 14123
8 EXTRACTED XBRL INSTANCE DOCUMENT revb-20230706_htm.xml XML 7139
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39603 | Film No.: 231076852
SIC: 2834 Pharmaceutical Preparations